Literature DB >> 4353773

Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.

B M Wolfe, J P Kane, R J Havel, H P Brewster.   

Abstract

Splanchnic metabolism of triglycerides and other major substrates was studied in the postabsorptive state in normotriglyceridemic and hypertriglyceridemic human subjects who received (1/2) g of clofibrate four times daily for 3 wk. Transport in blood plasma of triglycerides produced in the splanchnic region was quantified by three methods: (a) measurement of the transsplanchnic gradient of (14)C-labeled triglycerides during constant intravenous infusion of [1- (14)C] palmitate (b) chemical measurement of the transplanchnic gradient in concentration of triglycerides of very low density lipoproteins; and (c) determination of clearance of (14)C-labeled triglycerides in extrasplanchnic tissues. The first method measures only triglycerides derived from free fatty acids and the last two measure total splanchnic production. In hypertriglyceridemic subjects treated with clofibrate, average rates of total splanchnic production of triglycerides and production from free fatty acids were the same as those of comparable untreated subjects despite a consistent fall in plasma triglyceride levels. The hypotriglyceridemic effect of the drug was therefore accompanied by improved disposal of triglycerides in extrasplanchnic tissues. In treated normotriglyceridemic subjects, unlike their untreated counterparts, total splanchnic production was significantly higher than production from free fatty acids. Failure of clofibrate to reduce triglyceride levels in normotriglyceridemic subjects may have been related to increased total splanchnic production, coupled with improved extrasplanchnic disposal. Systemic transport and net splanchnic uptake of free fatty acids were similar in treated and control subjects but the fraction of [1-(14)C]palmitate converted to acetoacetate in splanchnic tissues was significantly higher in treated subjects. Net splanchnic extraction of plasma amino acids that enter the glucogenic pathway via pyruvate was increased in treated subjects and their arterial concentrations were reduced.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4353773      PMCID: PMC333015          DOI: 10.1172/JCI107399

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  AN EXPERIMENTAL APPROACH TO THE PROBLEM OF DISORDERED LIPID METABOLISM.

Authors:  J M THORP
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

2.  VALIDATION OF AN INCOMPLETELY COUPLED TWO-COMPARTMENT NONRECYCLING CATENARY MODEL FOR TURNOVER OF LIVER AND PLASMA TRIGLYCERIDE IN MAN.

Authors:  J W FARQUHAR; R C GROSS; R M WAGNER; G M REAVEN
Journal:  J Lipid Res       Date:  1965-01       Impact factor: 5.922

3.  EFFECTS OF ALPHA-P-CHLOROPHENOXYISOBUTYRYL ETHYL ESTER (CPIB) WITH AND WITHOUT ANDROSTERONE ON CHOLESTEROL BIOSYNTHESIS IN RAT LIVER.

Authors:  D R AVOY; E A SWYRYD; R G GOULD
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

4.  Urea metabolism in man.

Authors:  M WALSER; L J BODENLOS
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

5.  An automatic method for colorimetric analysis.

Authors:  L T SKEGGS
Journal:  Am J Clin Pathol       Date:  1957-09       Impact factor: 2.493

6.  The activity of the different carnitine acyltransferases in the liver of clofibrate-fed rats.

Authors:  H E Solberg; M Aas; L N Daae
Journal:  Biochim Biophys Acta       Date:  1972-11-30

7.  Lipoprotein lipase activity in human adipose tissue: assay methods. Relations to the serum triglyceride level in a normolipidemic population. The effect of ethyl chlorophenoxy isobutyrate.

Authors:  B Persson; G Schröder; B Hood
Journal:  Atherosclerosis       Date:  1972 Jul-Aug       Impact factor: 5.162

8.  Dynamics of plasma triglyceride turnover in man.

Authors:  W G Ryan; T B Schwartz
Journal:  Metabolism       Date:  1965-12       Impact factor: 8.694

9.  Comparison between free amino acid levels in plasma deproteinated with picric acid and with sulfosalicylic acid.

Authors:  W D Block; M E Markovs; B F Steele
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

10.  Clofibrate and nafenopin (SU-13437): effects on plasma clearance and tissue distribution of chylomicron triglyceride in the dog.

Authors:  R J Cenedella
Journal:  Lipids       Date:  1972-10       Impact factor: 1.880

View more
  11 in total

1.  Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

Authors:  J R Patsch; A M Gotto; T Olivercrona; S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

3.  [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].

Authors:  P Weisweiler; P Schwandt
Journal:  Klin Wochenschr       Date:  1977-08-15

4.  Role of branched-chain 2-oxo acid dehydrogenase and pyruvate dehydrogenase in 2-oxobutyrate metabolism.

Authors:  R Paxton; P W Scislowski; E J Davis; R A Harris
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

Review 5.  The evaluation and treatment of hypercholesterolemia in primary care practice.

Authors:  W L Peters; A H Goroll
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

6.  Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

Authors:  J Shepherd; C J Packard; J M Stewart; R F Atmeh; R S Clark; D E Boag; K Carr; A R Lorimer; D Ballantyne; H G Morgan
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

7.  Effects of a 3-day fast and of ethanol on splanchnic metabolism of FFA, amino acids, and carbohydrates in healthy young men.

Authors:  B M Wolfe; J R Havel; E B Marliss; J P Kane; J Seymour; S P Ahuja
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

8.  Effects of intravenously administered fructose and glucose on splanchnic amino acid and carbohydrate metabolism in hypertriglyceridemic men.

Authors:  B M Wolfe; S P Ahuja; E B Marliss
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

9.  Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.

Authors:  H S Paul; S A Adibi
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

10.  Branched chain amino acid oxidation in cultured rat skeletal muscle cells. Selective inhibition by clofibric acid.

Authors:  W M Pardridge; D Casanello-Ertl; L Duducgian-Vartavarian
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.